SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-058862
Filing Date
2022-05-11
Accepted
2022-05-11 17:06:45
Documents
13
Period of Report
2022-05-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2215079d1_8k.htm   iXBRL 8-K 64534
  Complete submission text file 0001104659-22-058862.txt   342203

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abbv-20220506.xsd EX-101.SCH 5512
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20220506_def.xml EX-101.DEF 31848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20220506_lab.xml EX-101.LAB 46738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20220506_pre.xml EX-101.PRE 29917
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2215079d1_8k_htm.xml XML 14191
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 22914649
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences